جست‌وجوی استاد و پژوهشگر

• Gut Microbiome
• Paediatric Immunology
• Mucosal Immunology
• +۵ مورد دیگر

Dr. Mona Bajaj-Elliott serves as Associate Professor in the Department of Infection, Immunity & Inflammation at University College London's Great Ormond Street Institute of Child Health (Faculty of Population Health Sciences). She concurrently holds the position of Co-Departmental Graduate Tutor at UCL. External appointments include Lecturer for the MSc Cancer program at the University of Nottingham, External Reviewer for Oxford's MSc Experimental Immunology, membership on the British Society of Gastroenterology's Gut Microbiome for Health Expert Panel, and Scientific Officer at BoobyBiome since April 2022. Her educational background includes a PhD from Birkbeck College (1984) and a BSc (Hons) from the University of London (1980). Her research centers on the gut microbial-immune axis in pediatric contexts, with five primary focus areas: (a) Gut microbiome dynamics in hematopoietic stem cell transplantation outcomes, (b) Microbial metabolite impacts on gastrointestinal homeostasis, (c) Gut microbiome roles in infant development, (d) Microbiome contributions to antimicrobial resistance, and (e) Mucosal defense mechanisms in infection and food allergy. Her laboratory investigates host-microbe-food antigen interactions at mucosal surfaces. Analysis of her 15 most recent publications reveals dominant research themes in pediatric microbiome-immunology interfaces, with significant emphasis on stem cell transplantation, renal transplantation, and infant/maternal microbiome dynamics. Key methodological approaches include longitudinal microbiome tracking, metabolome analysis, and translational models of infection and inflammation. Her work consistently bridges basic microbial science with clinical pediatric applications. Teaching responsibilities encompass Module Directorship for Acute & Chronic Infectious Diseases (BSc Population Health Year 2), co-direction of Epidemiological Transition (BSc Year 1) and Personalised Medicine (MSc) modules, and cross-faculty instruction on gut microbiome roles in intestinal/extraintestinal health including mental health connections. Her work aligns with UN Sustainable Development Goal 3 (Good Health and Well-Being).

Ayşegül Kuşkucuمشاهده پروفایل

دانشیار

• Medical Genetics
• Molecular Biology
• Cancer Research
• +۴ مورد دیگر

Assoc. Prof. Dr. Ayşegül Kuşkucu is an academic staff member at Yeditepe University Faculty of Medicine , Department of Medical Genetics . She holds a PhD in Genetics from Istanbul University (2008) and a specialization in Molecular Cytogenetics from Université Montpellier I (2009). Current research focuses on miRNA regulation in chordomas, cancer stem cells, and metabolic-genetic interactions in cancer models Key projects include TÜBİTAK-funded studies on PD-L1 CAR-NK cell therapy, caloric restriction epigenetics, and amniotic cell differentiation Her award includes First Place Oral Presentation at the International Medical Genetics Congress She supervises PhD and Master's theses on topics like obesity genetics, stem cell differentiation, and cancer epigenetics. Her work appears in journals such as Biological Research , Neurology India , and Gene , with recurring themes in oncomiR profiling , hypoxia-related polymorphisms , and genetic counseling . Administrative roles include Department Chair (2013) and Faculty Board Membership (2021). She actively participates in societies like the European Society of Human Genetics and Medical Genetics Association .

Melissa Mannersمشاهده پروفایل

استادیار

• Neuroscience
• Molecular Neuroscience
• Stress Neurobiology
• +۳ مورد دیگر

Melissa Manners, Ph.D., serves as Assistant Professor in the Department of Biological & Biomedical Sciences at Rowan University's College of Science & Mathematics, with additional teaching appointments at St. Joseph's University in Neuroscience graduate programs. Education: BA in Biology (Minor in Psychology), Rutgers University (2007) PhD in Pharmacology and Physiology, Drexel University College of Medicine (2016) Postdoctoral Fellowship, University of Pennsylvania (2016-2019) Research Focus: Dr. Manners investigates molecular mechanisms underlying chronic stress behavioral effects through neuroscience , molecular biology , and bioinformatics approaches. Her work examines gene expression alterations in disease states, drug treatment responses, and stress-induced neuroinflammation, with emphasis on sex differences and transgenerational effects. Key areas include: Stress neurobiology and resilience mechanisms Neuropharmacology of depression and opioids Molecular pathways in neurological disorders Epigenetic regulation in pain and stress Publication Trends: Recent work (2022-2025) reveals strong focus on sex-specific stress responses, gut microbiome-opioid interactions, and neuroinflammatory mechanisms using rodent models. Her research bridges molecular neuroscience with translational applications for depression and addiction treatment. Scientific Awards: No awards or fellowships were documented in source materials. Mentorship: Dr. Manners actively trains undergraduate and graduate students, evidenced by co-authorships with Elias, A.Y. Zhang, A.G. White, M.J.Pyle, J.K. Brynildsen, M. Schechter, X Liu, D.Eacret, and N.L. Yohn. She teaches core neuroscience courses including Cellular & Molecular Neuroscience, Neurobiology of Stress, and Brain Behavior and Disease across both institutions. Research Infrastructure: Source materials did not specify laboratory facilities or research team compositions.

Sean Lawlerمشاهده پروفایل

دانشیار

• Brain Cancer Therapy
• Translational Oncology
• Blood-Brain Barrier
• +۵ مورد دیگر

Sean Lawler, Ph.D. is an Associate Professor of Pathology and Laboratory Medicine at Brown University, leading the Brain Cancer Therapy Lab. He is affiliated with the Brown Cancer Center as co-leader of the CNS Cancer Translational Disease Research Group. Specializes in translational approaches for brain tumor therapy Previous faculty appointments at Harvard, Ohio State, and University of Leeds Focus on glioblastoma and pediatric high-grade glioma Research interests include: Drug delivery across the blood-brain barrier Immunotherapy development for brain cancers Role of cytomegalovirus in glioblastoma progression His lab explores three main areas: blood-brain barrier modulation, immune system activation against brain tumors, and CMV-induced cancer growth mechanisms. Recent publications emphasize glioblastoma immunology, drug delivery innovations, and tumor microenvironment dynamics, particularly through STING activation and peptide-drug conjugates. Dr. Lawler teaches BIOL 1295 - Fundamentals of Cancer Immunotherapy at Brown University.

Amir A. Sadighi Akhaمشاهده پروفایل

پژوهشگر

• Immunology
• Clinical Immunology
• Autoimmune Disorders
• +۴ مورد دیگر

Amir A. Sadighi Akha, M.D., Ph.D., is a faculty member at the Mayo Clinic Department of Laboratory Medicine and Pathology. He holds a D.Phil in Immunology from the University of Oxford and an M.D. from the University of Tehran School of Medicine, with postdoctoral training in immunopathology at Johns Hopkins University School of Medicine. Education 1999: Fellow, Immunopathology & Pediatric Immunology, Johns Hopkins University 1996: D.Phil in Immunology, University of Oxford 1991: M.D., University of Tehran His research focuses on immunological mechanisms in aging, autoimmune disorders, and clinical cytometry for immunodeficiencies. Recent work includes: Development of diagnostic frameworks for primary immunodeficiencies Investigation of genetic variants in immune dysregulation Multiomics modeling for predictive biomarkers in infectious diseases Studies on cytokine signaling and mucosal immunity in mouse models Notable scientific awards include the 1991 Iranian Presidential Certificate of Appreciation for top graduate status and the 2004 Keble College Senior Common Room appointment. Professional Memberships Clinical Immunology Society (2025–present) Federation of Clinical Immunology Societies (2024–present) Association of Medical Laboratory Immunologists (2023–present) He contributes to Mayo Clinic's Centers of Excellence and pediatric clinical programs, with expertise in flow cytometry and anti-cytokine autoantibody analysis.

Anne Kenworthyمشاهده پروفایل

استاد

• Biophysics
• Structural Biology
• Cell and Developmental Biology
• +۳ مورد دیگر

Anne Kenworthy is a Professor in the Department of Molecular Physiology and Biological Physics at the University of Virginia. Her research focuses on the architecture and function of biological membranes, with a particular emphasis on lipid rafts and caveolae in health and disease. Primary Appointment: Professor, Molecular Physiology and Biological Physics, University of Virginia Education: BA in Biology from Kenyon College, PhD in Cell Biology from Duke University School of Medicine Postdoctoral Training: Biophysics at Johns Hopkins University, Cell Biology at NIH Her work combines live cell imaging, biophysics, structural analysis, and biochemical approaches to investigate: How proteins and lipids cooperate to form lipid rafts Exploitation of rafts by bacterial toxins Cholesterol's role in Alzheimer's disease Caveolin-1 mutations in breast cancer and pulmonary hypertension Structural basis for caveolae formation Recent studies highlight lipid peroxidation effects on phase separation, caveolin mutation structural analysis, and toxin-membrane interactions. She has contributed extensively to understanding membrane microdomains through 15 recent publications spanning 2024–2020. Her lab employs advanced techniques including: Fluorescence Recovery After Photobleaching (FRAP) Single Particle Electron Microscopy AlphaFold2 Structural Prediction High-Content Imaging Platforms The research has implications for neurodegenerative diseases, cancer, and infectious disease mechanisms.

Swapnil Sonkusareمشاهده پروفایل

استاد

• Biophysics
• Cardiovascular Biology
• Physiology
• +۲ مورد دیگر

Swapnil Sonkusare is a Professor in the Department of Molecular Physiology and Biological Physics at the University of Virginia School of Medicine and the Director of Graduate Studies in Physiology. His research focuses on calcium signaling mechanisms in vascular function and dysfunction, particularly in hypertension, obesity, pulmonary hypertension, and atherosclerosis. He leads the Sonkusare Laboratory at the Robert M. Berne Cardiovascular Research Center. Key Research Areas: Biophysics, Cardiovascular Biology, Physiology, Calcium Signaling, TRP Channels. Techniques: Transgenic mouse models, high-speed confocal imaging, patch-clamp electrophysiology, dSTORM super-resolution imaging. Sonkusare’s lab investigates how TRP ion channels interact with other signaling proteins to regulate blood pressure and vascular tone. His work has identified novel calcium signaling nanodomains in smooth muscle cells and elucidated the role of endothelial TRPV4 channels in pulmonary hypertension and obesity-induced hypertension. His lab’s recent publications highlight discoveries in mechanosensitive signaling , purinergic-TRPV4 pathways , and oxidative stress in vascular dysfunction . Collaborative studies with Dr. Venetia Laubach on lung ischemia-reperfusion injury have been featured in Science Signaling and Circulation . Scientific Awards: Mid-Career Award in Cardiovascular Pharmacology (ASPET, 2022). Dean’s Excellence in Faculty Research Award (UVA, 2022). Grants: Multiple NIH R01 grants (HL167208, HL142808, HL146914, EY034238, HL157407) fund his work on TRPV4 signaling, calcium nanodomains, and vascular inflammation. Labs & Teams: Based at the Robert M. Berne Cardiovascular Research Center, his lab collaborates with institutions like Johns Hopkins, McGill University, and the University of Maryland. Current members include Research Scientists Yen-Lin Chen and Maniselvan Kuppusamy, with former students Matteo Ottolini (now at Bayer Oncology) and Corina Marziano (Analytical Scientist at Medpace).

• Proteomics
• Metabolomics
• Plant-Microbe Interactions
• +۳ مورد دیگر

Prof. Dr. Karsten Niehaus serves as Head of the Proteome and Metabolome Research Group at the Center for Biotechnology (CeBiTec) and Faculty of Biology, University of Bielefeld. His research focuses on proteomics and metabolomics applications in plant-microbe interactions, bacterial stress responses, and disease model systems. His laboratory employs advanced mass spectrometry imaging and cell phenotyping technologies to investigate molecular responses in crops like sugar beet and grapevines under abiotic stress conditions, as well as in cancer models where differentiation therapy impacts tumor malignancy. The group also explores microbial biotechnology through Xanthomonas campestris studies on xanthan production and stress adaptation. Selected publications highlight innovations in 3D microfluidics for biomarker detection and bioinformatics platforms like MetHoS for metabolomics data analysis. His work appears in journals covering Frontiers in Plant Science , Scientific Reports , and Journal of Experimental Botany . Contact: kniehaus@cebitec.uni-bielefeld.de | Office: UHG W7-117

• Cell Stress Signaling
• MAP Kinase Pathways
• Ageing and Cellular Repair
• +۲ مورد دیگر

Professor Simon Holst Bekker-Jensen is affiliated with the University of Copenhagen , specifically the Faculty of Health and Medical Sciences and the Department of Cellular and Molecular Medicine . He leads research at the Molecular Aging Program Damage and Repair Center for Healthy Aging , focusing on stress signaling pathways in cellular biology. Academic Rank: Professor Department: Cellular and Molecular Medicine Research Center: Molecular Aging Program Damage and Repair Center for Healthy Aging His research investigates MAP kinase activation mechanisms under stress , novel stress signaling pathways , and the role of cellular stress responses in cancer . Using siRNA screens , proteomics , and biochemical techniques , he explores RNA-binding proteins and post-transcriptional regulation in stress and inflammation. Current projects target ZAKα kinase and NLRP1 inflammasome dynamics, with potential therapeutic applications in cancer and inflammatory disorders. Collaborations span international institutions, with recent external partnerships in multiple countries. He serves as a consultant for KinxeaTherapeutics , developing kinase inhibitors for clinical trials.

Xin Zhanمشاهده پروفایل

مدرس

• Medical Anthropology
• Reproductive Health
• Public Health
• +۳ مورد دیگر

Dr. Xin Zhan is an Affiliated Lecturer at the Department of Social Anthropology, University of Cambridge. Her research bridges anthropological frameworks with health sciences, focusing on maternal-fetal interactions, nutritional epidemiology of BRCA-related cancers, and neurodevelopmental impacts of inflammation. Department of Social Anthropology Email: xz434@cam.ac.uk Her publications (2006–2024) explore: Maternal gut microbiome effects on fetal neurodevelopment Vitamin D/calcium supplementation in high-risk breast cancer Precision medicine approaches to inflammation-depression links Genetic polymorphisms in DNA repair and cancer progression Current work emphasizes cross-disciplinary collaboration between anthropology and biomedical sciences.

• Decision-Making Neurobiology
• Reward Processing
• Psychopathology
• +۶ مورد دیگر

Jessica A. Cooper is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine, where she serves as Assistant Director of the Translational Research in Affective Disorders (TReAD) Laboratory under Dr. Michael Treadway. Her research focuses on decision-making neurobiology and reward processing , examining how stress, aging, individual differences, and inflammatory processes impact reinforcement learning and motivational circuits. Key areas include computational phenotyping of effort-based decision-making in depression and psychosis, inflammation-depression interactions, and sex-specific drug effects on reward processing. Analysis of her recent publications reveals a strong emphasis on translational immunopsychiatry , particularly TNF-alpha antagonism trials for motivational deficits in high-inflammation depression, alongside innovative work on spontaneous thought dynamics and social learning across the lifespan. While no specific awards are listed in available sources, her work demonstrates significant contributions to understanding corticostriatal circuitry in affective disorders through multimodal approaches including fMRI, computational modeling, and pharmacological challenges. As Assistant Director of the TReAD Lab, Dr. Cooper mentors research staff and contributes to studies investigating neural mechanisms of depression, with particular focus on stress-induced alterations in glutamatergic signaling and inflammatory pathways. The laboratory maintains active collaborations across Emory's neuroscience and immunology departments. The TReAD Lab operates within Emory's robust neuroscience ecosystem, utilizing advanced neuroimaging facilities and maintaining partnerships with clinical departments for patient recruitment in mechanistic treatment trials.

• Lung cancer
• Immunobiology of lung cancer
• Translational research
• +۵ مورد دیگر

Steven M. Dubinett is Director of the UCLA Clinical & Translational Science Institute, Associate Vice Chancellor, and Senior Associate Dean for Translational Research at the UCLA David Geffen School of Medicine. He holds professorships in Medicine, Pathology and Laboratory Medicine, and Molecular and Medical Pharmacology. Dr. Dubinett oversees the translation of UCLA biomedical discoveries into medical products and health interventions, integrating research infrastructure through the CTSI. Previously, he chaired the Executive Committee of UC Biomedical Research Acceleration, Integration, and Development (UC BRAID), which integrates clinical and translational research across the University of California system. MD: Rutgers New Jersey Medical School (1980) Internship: University Hospital, Newark (1981) Residency: UCLA (1983) Chief Resident: UCLA (1984) Fellowship: Massachusetts General Hospital (Pulmonary Medicine, 1988) Resident Fellow: Harvard Medical School (Tumor Immunology, 1988) Dr. Dubinett's research focuses on the immunobiology of lung cancer, with particular emphasis on understanding inflammation and immunity in lung cancer pathogenesis. His laboratory has developed translational research programs that bridge basic discoveries to clinical applications, particularly in non-small cell lung cancer. His work spans from molecular mechanisms of tumor microenvironment regulation to clinical implementation of novel diagnostics and therapeutics. He has pioneered research on exosome-mediated metastasis, dendritic cell vaccines, and biomarker development for early lung cancer detection. Analysis of Dr. Dubinett's recent publications reveals a strong emphasis on lung cancer interception strategies, tumor microenvironment characterization, and novel immunotherapeutic approaches. His work increasingly integrates multi-omics approaches, single-cell technologies, and liquid biopsy development to understand lung cancer evolution from premalignant stages. His research bridges basic molecular mechanisms with clinical applications, particularly in developing non-invasive diagnostics and combination immunotherapies. U.S. Department of Veterans Affairs 2019 William S. Middleton Award American Lung Association 2019 Lung Force Honoree Barlow Respiratory Hospital 2014 Medical Excellence Award American Thoracic Society Recognition Award for Scientific Accomplishments (2008) The Stanley Blatt Award for Lung Cancer Research (1999) Dr. Dubinett has trained more than 45 graduate students, post-doctoral fellows, and junior faculty, nearly all of whom have continued in academic or industry research careers. His research program is supported by numerous NIH grants including multiple R01s, P50 SPORE grants, and U01/U24 projects. As Director of the UCLA CTSI, he oversees a $69.6 million Clinical and Translational Science Award that supports infrastructure for translational research. He has served as Principal Investigator on numerous projects focused on lung cancer biomarkers, early detection, and novel therapeutics, including a Phase I trial of intratumoral dendritic cell vaccines. Dr. Dubinett leads the UCLA Lung Cancer Biomarker Development Laboratory and serves as Chair of the Research Evaluation Panel for biospecimen utilization for the American College of Radiology Imaging Network/National Lung Screening Trial. His research team employs advanced genomic, proteomic, and imaging technologies to characterize lung cancer development from premalignant stages through metastatic disease. The laboratory maintains extensive collaborations with both basic science and clinical investigators across UCLA and the broader University of California system.

• Respiratory Immunology
• Lung Fibrosis
• Tissue-Resident Immune Cells
• +۲ مورد دیگر

Ling-Pei Ho , MD, FRCP, is a Professor of Respiratory Immunology at the University of Oxford within the Nuffield Department of Medicine . She serves as a Consultant in Respiratory Medicine and leads the NIHR BRC Respiratory Theme. Her research focuses on immune mechanisms in lung fibrosis, epithelial regeneration, and translational immunology. Affiliated Institutions: University of Oxford Oxford Sarcoidosis Service NIHR Oxford BRC Respiratory Theme MRC Translational Immunology Discovery Unit Research Themes: The Ho Group investigates the role of tissue-resident immune cells (innate lymphoid cells, Tregs, alveolar macrophages) in lung homeostasis and repair. Key methodologies include spatial transcriptomics and single-cell imaging mass cytometry for mapping immune cell dynamics in lung injury and regeneration. Publication Trends: Recent work spans idiopathic pulmonary fibrosis, COVID-19 immunopathology, and sarcoidosis. Studies emphasize spatial omics, longitudinal murine models, and clinical translation, with a focus on interferon signaling, myeloid cell activation, and fibrotic progression. Contact: For DPhil opportunities or collaborations, email ling-pei.ho@imm.ox.ac.uk .

Jin Mo Chungمشاهده پروفایل

استاد

• Chronic Pain
• Neuropathic Pain
• Synaptic Plasticity
• +۷ مورد دیگر

Jin Mo Chung is a Professor and Chair at the University of Texas Medical Branch (UTMB), holding the Cecil H. and Ida M. Green Distinguished University Endowed Chair in Neuroscience and Cell Biology. His work focuses on chronic pain mechanisms, particularly neuropathic pain, where he developed the foundational 'spinal nerve ligation (SNL) Chung Model' for testing analgesics. With over 160 peer-reviewed publications and 23,000 citations, his research has been NIH-funded for 35 years, including multiple R01 and Program Project Grants. Education: BS in Physics, Sogang University PhD in Physiology, Loyola-Stritch School of Medicine Post-Doctoral in Neurophysiology, Loyola-Stritch Post-Doctoral in Somatosensory Neurophysiology, UTMB Chung's research spans synaptic plasticity in pain pathways, reactive oxygen species (ROS) in chronic pain, and treatment strategies for conditions like spinal cord injury, diabetic neuropathy, HIV infection, and chemotherapy-induced pain. He has pioneered animal models for pain research and explored interventions like spinal cord stimulation, antioxidant therapy, and electroacupuncture. The 15 most recent articles reflect a focus on pain neurobiology, ROS signaling, neuroinflammation, and neuromodulation techniques. Key subfields include FGF13 in diabetic neuropathy, Wnt5a signaling in HIV-related pain, opioid-induced hyperalgesia, circadian regulation of chemotherapy pain, and neuron-type-specific spinal cord stimulation. Scientific Contributions: Developed the 'Chung Model' of spinal nerve ligation Over 160 peer-reviewed publications NIH R01 and Program Project Grants (35 years) Co-editor of Encyclopedia of Pain Chung has mentored 30 postdoctoral fellows and 22 visiting scientists. He co-founded the Association of Korean Neuroscientists and led the Gulf Coast Consortium and Texas Pain Research Consortium. His work connects basic science to clinical applications, with global impacts on analgesic drug development.

Andrea De Vizcaya Ruizمشاهده پروفایل

استاد

• Environmental Toxicology
• Particulate Matter (PM2.5/PM10)
• Nanotoxicology
• +۴ مورد دیگر

Andrea De Vizcaya Ruiz is a Professor in the Department of Environmental and Occupational Health at the University of California, Irvine (UCI) School of Public Health . She is Graduate Program Director for Environmental Health Sciences and leads research at key centers including the Center for Occupational and Environmental Health (COEH) , Air Pollution Health Effects Lab (APHEL) , and AirUCI Atmospheric Integrated Research Unit . Her expertise spans environmental toxicology, nanotoxicology, and air pollution health impacts , with a focus on particulate matter (PM), microplastics, and nanomaterials. Educational Background: Bachelor's in Veterinary Medicine, National Autonomous University of Mexico (UNAM) Doctorate in Toxicology, University of Surrey, UK Research Interests center on toxic effects of environmental pollutants , including: Health impacts of particulate matter (PM2.5/PM10) Toxicokinetics of nanomaterials Oxidative stress and inflammation mechanisms Health equity in environmental exposure Neurotoxic and cardiorespiratory effects Biomarker development for toxicity assessment Recent Publications highlight her work on PM-induced nephrotoxicity, nanoparticle neurotoxicity, and synergies between urban pollutants and metabolic stressors . Her studies frequently employ in vitro and in vivo models to dissect toxicity pathways. Scientific Awards: 2011 Young Investigator Award, Society of Toxicology, USA 2015 1st place BioNanoTechnology Award, Cinvestav and Neolpharma Inc., Mexico City Student Mentorship includes advising PhD and MSc students like Aidee Solorio Rodriguez and Josefina Poblano Bata, with their work presented at international conferences including the International Nanotoxicology Congress and IUTOX Trainee Awards. Labs & Collaborations: She actively collaborates with research groups in Mexico, the Netherlands, Canada, and the US, integrating toxicology, aerosol science, and public health to address evolving biotechnology challenges. Her advisory roles for the Mexican Ministry of Health and Environment further demonstrate her policy impact.